Norcross, GA, United States of America

Charles A Kunsch

This inventor holds 17 USPTO granted patents and 1 published patent application and 2 EPO patents, primarily in Molecular Biology. Top assignees: Human Genome Sciences, Inc., Atherogenics, Inc.. Active years: 1998-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles A Kunsch. Retrieved from https://idiyas.com/inventor/charles-a-kunsch

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17 

% Patents Active = 52.9


Average Co-Inventor Count = 4.5

ph-index = 10

Forward Citations = 492(Granted Patents)


Location History:

  • Germantown, MD (US) (1998)
  • Gaithersburg, MD (US) (2000 - 2004)
  • Atlanta, GA (US) (2006)
  • Norcross, GA (US) (2002 - 2012)

Company Filing History:


Years Active: 1998-2012

Loading Chart...
Loading Chart...
Areas of Expertise:
Polynucleotides
Streptococcus Pneumoniae
Cytoprotective Response
Antigens
Vaccines
Human BTG-2
Human B-cell Translocation
Staphylococcus Aureus
Enterococcus Faecalis
Diagnostic Methods
Inflammation
Oxidative Stress
17 patents (USPTO):Explore Patents

Title: The Innovations of Charles A. Kunsch

Introduction

Charles A. Kunsch is a notable inventor based in Norcross, Georgia, with a remarkable portfolio of 17 patents. His work primarily focuses on advancements in biotechnology, particularly in the areas of polynucleotide sequences and cytoprotective response elements. Kunsch's inventions have significant implications for medical research and therapeutic applications.

Latest Patents

Among his latest patents, Kunsch has developed innovative polynucleotide sequences of the genome, which include polypeptide sequences encoded by these polynucleotides. His inventions also encompass vectors and hosts that utilize these polynucleotides, along with assays and various applications. Another significant patent addresses protection against oxidative stress and inflammation through a cytoprotective response element. This invention details regulatory DNA sequences that enhance the protective capabilities of cells against oxidative damage, particularly during conditions of hemodynamic shear stress.

Career Highlights

Kunsch has had a distinguished career, contributing to prominent companies such as Human Genome Sciences, Inc. and Atherogenics, Inc. His work in these organizations has furthered the understanding and application of genetic research in therapeutic contexts.

Collaborations

Throughout his career, Kunsch has collaborated with esteemed colleagues, including Craig A. Rosen and Gil H. Choi. These partnerships have fostered innovation and advancement in the field of biotechnology.

Conclusion

Charles A. Kunsch's contributions to biotechnology through his patents and collaborations highlight his significant role as an inventor. His work continues to influence the landscape of genetic research and therapeutic development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…